Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,471 | 1,001 | 97.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 2.8% |
| Education | $42.05 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,029 | 190 | $0 (2024) |
| Abbott Laboratories | $1,940 | 50 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,447 | 86 | $0 (2023) |
| Lilly USA, LLC | $1,177 | 67 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $926.25 | 28 | $0 (2024) |
| Amgen Inc. | $825.73 | 44 | $0 (2024) |
| Mannkind Corporation | $664.43 | 43 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $651.64 | 42 | $0 (2024) |
| Corcept Therapeutics | $631.35 | 39 | $0 (2024) |
| Insulet Corporation | $605.16 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,924 | 129 | Abbott Laboratories ($761.43) |
| 2023 | $3,234 | 174 | Novo Nordisk Inc ($449.03) |
| 2022 | $3,264 | 160 | Abbott Laboratories ($659.06) |
| 2021 | $1,485 | 98 | Novo Nordisk Inc ($271.75) |
| 2020 | $16.76 | 1 | Insulet Corporation ($16.76) |
| 2019 | $989.65 | 62 | AstraZeneca Pharmaceuticals LP ($143.24) |
| 2018 | $3,516 | 242 | Novo Nordisk Inc ($797.81) |
| 2017 | $2,583 | 142 | SANOFI-AVENTIS U.S. LLC ($654.20) |
All Payment Transactions
1,008 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/10/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: Endocrinology | ||||||
| 12/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $45.43 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: Endocrinology | ||||||
| 11/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: Diabetes Care | ||||||
| 11/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: Diabetes Care | ||||||
| 11/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $0.54 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $116.34 | General |
| Category: Diabetes Care | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Diabetes Care | ||||||
| 11/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiology | ||||||
| 10/28/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 307 | 758 | $146,853 | $48,795 |
| 2022 | 7 | 436 | 1,075 | $182,737 | $67,031 |
| 2021 | 6 | 231 | 432 | $70,623 | $27,400 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 406 | $109,620 | $35,603 | 32.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 62 | 150 | $10,950 | $3,818 | 34.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 57 | 152 | $10,687 | $3,719 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $9,858 | $3,657 | 37.1% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 19 | 19 | $5,738 | $1,998 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 135 | 383 | $103,410 | $34,309 | 33.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 50 | 203 | $20,300 | $9,965 | 49.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 77 | 77 | $24,486 | $9,280 | 37.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 50 | 111 | $8,400 | $4,121 | 49.1% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 55 | 153 | $10,757 | $3,871 | 36.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 49 | 128 | $9,344 | $3,269 | 35.0% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 20 | 20 | $6,040 | $2,216 | 36.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 161 | $43,421 | $15,916 | 36.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 43 | 43 | $13,674 | $4,885 | 35.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 25 | 90 | $4,500 | $2,863 | 63.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2021 | 39 | 64 | $4,500 | $1,654 | 36.8% |
| 99439 | Chronic care management services, each additional 20 minutes of clinical staff time per calendar month | Office | 2021 | 20 | 38 | $1,900 | $1,086 | 57.2% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 26 | 36 | $2,628 | $995.76 | 37.9% |
About Dr. Dina Rivera, MD
Dr. Dina Rivera, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1932384807.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dina Rivera, MD has received a total of $18,014 in payments from pharmaceutical and medical device companies, with $2,924 received in 2024. These payments were reported across 1,008 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($17,471).
As a Medicare-enrolled provider, Rivera has provided services to 974 Medicare beneficiaries, totaling 2,265 services with total Medicare billing of $143,227. Data is available for 3 years (2021–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location San Antonio, TX
- Active Since 01/09/2008
- Last Updated 10/31/2013
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1932384807
Products in Payments
- FARXIGA (Drug) $1,204
- Ozempic (Drug) $1,192
- FREESTYLE LIBRE 3 (Device) $1,114
- AFREZZA (Drug) $664.43
- Korlym (Drug) $631.35
- JARDIANCE (Drug) $614.14
- Omnipod (Device) $605.16
- INVOKANA (Drug) $573.51
- TOUJEO (Drug) $544.47
- Repatha (Biological) $543.33
- Rybelsus (Drug) $504.30
- Pogo Automatic Blood Glucose Monitoring System (Device) $436.07
- CeQur Simplicity (Device) $407.85
- Minimed 670G System (Device) $376.05
- Victoza (Drug) $368.73
- FREESTYLE LIBRE (Device) $368.23
- LEQVIO (Drug) $347.69
- MOUNJARO (Drug) $334.87
- Saxenda (Drug) $331.33
- FREESTYLE LIBRE 2 (Device) $307.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in San Antonio
Eugenio Cersosimo, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1.3M
Ralph Defronzo, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1.3M
Firas Akhrass, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $868,751
Dr. Jeannie Baquero, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $668,321
Kathleen Hands, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $609,314
Carolina Solis-Herrera, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $481,511